Lipids profile in vitamin D insufficient/deficient subjects with different genotypes of vitamin D receptor gene

Background. Recent studies have demonstrated possible association between vitamin D deficiency and atherogenic dyslipidemia. However, there are practically no results from Russian investigations in this field.

Objective. To assess serum lipids in women carrying various vitamin D receptor (VDR) gene variants.

Design and methods. The study included 697 women aged between 35 to 55 years (mean age 43,4 ± 0,3 years). Anthropometric data including height, waist circumference, body mass index were measured. Serum lipid profile, 25-hydroxyvitamin D (25(OH)D) level and four VDR gene polymorphisms BsmI (rs1544410), ApaI (rs7975232), TaqI (rs731236), and FokI (rs2228570) were evaluated.

The results showed high prevalence of abdominal obesity, dyslipidemia, vitamin D insufficiency/deficiency in the study group and 2,6 increased risk of high-density lipoprotein (HDL) cholesterol reduction in women with vitamin D deficiency. There were no differences in serum 25(OH)D between VDR genotypes. GG (BB) genotype carriers of BsmI (rs1544410) demonstrated higher triglyceride levels than subjects with GA, AA (Bb, bb) genotypes. Women with TT (AA) и TG (Aa) genotypes of ApaI (rs7975232) had higher total cholesterol and low-density lipoprotein (LDL) cholesterol levels compared to GG (aa) genotype carriers.

Conclusions. The study revealed the associations between low vitamin D status and decreased HDL cholesterol as well as between BsmI (rs1544410) and ApaI (rs7975232) VDR genotypes and atherogenic dyslipidemia.

1. Zodda D, Giammona R, Schifilliti S. Treatment strategy for dyslipidemia in cardiovascular disease prevention: focus on old and new drugs. Pharmacy (Basel). 2018;6(1):10. doi:10.3390/pharmacy6010010

2. Meshkov AN, Ershova AI, Deev AI, Metelskaya VA, Zhernakova YuV, Rotar OP et al. Distribution of lipid profile values in economically active men and women in Russian F ederation: results of the ESSE-RF study for the years 2012-2014. Cardiovascular Therapy and Prevention. 2017;16(4):62-7. doi.org/10.15829/1728-8800-2017-4-62-67. In Russian.

3. Rotar OP, Libis RA, Isaeva EN, Erina AM, Shavshin DA, Moguchaya EV et al. Metabolic syndrome prevalence in Russian cities. Russian J Cardiol. 2012;2(94):55-62. doi:10.15829/1560-4071-2012-2-55-62. In Russian.

4. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-329. doi:10.1016/j.chembiol.2013.12.016

5. Mozos I, Marginean O. Links between Vitamin D deficiency and cardiovascular diseases. Biomed Res Int. 2015;2015:109275. doi:10.1155/2015/109275

6. Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012;126(3):270-7. doi:10.1161/CIRCULATIONAHA.111.077875

7. Pigarova EA, Rozhinskaya IY, Belaya ZE, Dzeranova LK, Karonova TL, Il’in AV et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016:62(4):60-84. doi:10.14341/probl201662460-8. In Russian.

8. Rebrova OYu. Statistical analysis of medical data. Application of programs STATISTICA. M.: MediaSphera, 2000. 312 p. In Russian.

9. Azevedo FR, Caramelli B. Hypovitaminosis D and obesity — coincidence or consequence. Eur Endocrinol. 2013;9 (2):128—131. doi:10.17925/EE.2013.09.02.128

10. Karonova TL, Grineva EN, Nikitina IL, Tsvetkova EV, Todieva AM, Belyaeva OD et al. The prevalence of vitamin D deficiency in the NorthWest region of the Russian Federation (St. Petersburg and Petrozavodsk). Osteoporosis and Bone Diseases. 2013;3:3-7. doi:10.14341/osteo201333-7. In Russian.

11. Papandreou D, Hamid ZTN. The role ofvitamin D in diabetes and cardiovascular disease: an updated review of the literature. Dis Markers. 2015;2015:580474. doi:10.1155/2015/580474

12. Grimes DS, Hindle E, Dyer T. Sunlight, cholesterol and coronary heart disease. QJM. 1996;89(8):579-589.

13. Gupta AK, Sexton RC, Rudney H. Effect of vitamin D3 derivatives on cholesterol synthesis and HMG-CoA reductase activity in cultured cells. J Lipid Res. 1989;30(3):379-86.

14. Sarmiento-Rubiano LA, Angarita Ruidiaz JA, Suarez Davila HF, Suarez Rodriguez A, Rebolledo-Cobos RC, Becerra JE. Relationship between serum vitamin D levels and HDL cholesterol in postmenopausal women from Colombian Caribbean. J Nutr Metab. 2018;2018:9638317. doi:10.1155/2018/96383170

15. Yin K, You Y, Swier V, Tang L, Radwan MM, Pandya AN et al. Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholestero-lemic swine. Arterioscler Thromb Vasc Biol. 2015;35(11):2432-2442. doi:10.1161/ATVBAHA.115.306132

16. Wagatsuma A, Sakuma K. Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res Int. 2014;121254:13 doi:10.1155/2014/121254

17. Lupton JR, Faridi KF, Martin SS, Sharma S, Kulkarni K, Jones SR et al. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study. J Clin Lipidol. 2016;10(1):72-81. doi:10.1016/j.jacl.2015.09.006

18. Schuch NJ, Garcia VC, Vivolo SR, Martini LA. Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome. Nutr J. 2013;12:96. doi:10.1186/1475-2891-12-96

19. Al-HazmiAS, Al-Mehmadi MM,Al-Bogami SM, ShamiAA, Al-Askary AA, Alomery AM et al. Vitamin D receptor gene polymorphisms as a risk factor for obesity in Saudi men. Electron Physician. 2017;9(10):5427-5433. doi:10.19082/5427

20. Tworowska-Bardzinska U, Lwow F, Kubicka E, Laczman-ski L, Jedzrzejuk D, Dunajska K et al. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecol Endocrinol. 2008;24(9):514-518. doi:10.1080/09513590802302985